FDA authorizes emergency use of convalescent plasma to treat COVID-19

The Benchmark Company’s Senior Equity Analyst, Aydin Huseynov, M.D., CFA. on emergency use of convalescent plasma to treat COVID-19
September 10, 2026
- September 17, 2026
13th Annual TMT One-on-One Conference
September 23, 2026
- September 24, 2026
2nd Annual Nuclear Innovation Summit
December 10, 2026